Pharma Pulse 4/10/25: Key Takeaways for AD Management, Coverage from LogiPharma Europe 2025 & more
The latest news for pharma industry insiders.
LogiPharma Europe 2025: Aligning People, Process, and Technology
The first day of LogiPharma Europe carried on with a panel discussion along the “Mastering Temperature-Controlled Operations” track. With a focus on ways to best aligning people, process and technology to meet the temperature-controlled operations demands of your future product pipeline, it featured Scott Clayton, director of supply chain at BioPhorum; Gerhard Eller, senior director of global logistics & trade compliance at Moderna; Linda Schwär, head of life sciences EMEA for Sensitech; Tony Fonk, president and CEO of Spotsee; and Jesper Schmidt, global head of air & ocean transportation at Teva.
Key Takeaways for AD Management
An expert discusses the existing gaps in atopic dermatitis (AD) management, promising areas of research to address unmet needs, and key takeaways from the discussion for the managed care audience regarding AD management.
Global Pharma Stocks Slide on Tariff Threat
Shares in large US and European drugmakers slide, underperforming amid a broad market slump, after President Donald Trump said the US was planning to announce “a major tariff on pharmaceuticals” soon. BMO Capital Markets Biotech and Pharma Analyst Evan Seigerman has more on the story. (Source: Bloomberg)
GSK plc has announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups working to boost adult immunization through improved vaccine education, outreach and access.
More on how AI-Powered Therapy Redefines Chronic Cough Care!
In this exclusive interview with Pharmaceutical Executive, Tamsin Chislett talks about Hyfe's digital therapeutic (DTx) which is blending AI-powered cough monitoring with Behavioral Cough Suppression Therapy (BCST).
This approach offers precise, fully customized home-based care for chronic cough. By digitizing BCST, Hyfe removes clinic barriers, offering global access to side-effect-free treatment.
In partnership with KYORIN Pharmaceutical Co., Ltd. the cough Dtx will first be launched in Japan. However, Hyfe is planning a global expansion of our DTx and aims to integrate our validated AI models into broader respiratory care platforms - targeting COPD, asthma, and long COVID, among others.
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
